Laura King is founder and CEO of Elucent Medical, a company that has developed a medical device to locate breast tumors in surgery while concurrently eliminating a painful and expensive wire localization procedure from breast cancer treatment. Prior to Elucent, Ms. King led NeuWave Medical, a Madison, WI-based startup that developed and commercialized a device to ablate cancer tumors in liver, kidney, lung, and bone. Ms. King led NeuWave Medical for seven years, successfully raising $33 million in venture capital and doubling revenue each year. Prior to joining the startup world, Ms. King was a GE company officer while leading the $1.2 billion Global Interventional Cardiology and Surgery business. Ms. King is also co-owner of Vino Veritas, a Wisconsin wine distribution company. Raised in San Francisco, she is a graduate of UC Davis in economics.